Replication of the herpes simplex virus type 1 RL1 mutant 1716 in primary neuronal cell cultures - Possible relevance to use as a viral vector

Journal of the Neurological Sciences

Volumn 179, Issue 1-2, 2000, Pages 108-114

  Kennedy, P G E ^a   Gairns, J ^a   MacLean, A R ^a,b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

1716; Herpes simplex virus; Neuron; RL1 mutant

Indexed keywords

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DELETION MUTANT; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HIPPOCAMPUS; IMMUNOFLUORESCENCE; NERVE CELL CULTURE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SPINAL GANGLION; VIRUS INFECTION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS VECTOR; VIRUS VIRULENCE;

ANIMAL; ASTROCYTES; CELL CULTURE; CELLS, CULTURED; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MUTATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; VIRUS REPLICATION;

EID: 0034306469     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00388-9     Document Type: Article

References (18)

1. Safe and efficient trans gene expression in the PNS and CNS of mice using ICP34.5 deletion mutants
2. The terminal A sequence of the Herpes Simplex Virus genome contains the promoter of a gene located in the repeat sequences of the L component
3. Mapping of Herpes Simplex Virus-1 neurovirulence to gamma, 34.5, a gene nonessential for growth in culture
4. ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells
5. + between immediate early gene 1 and the 'a' sequence
6. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2
7. Peripheral replication and latency kinetics of the HSV1 non-virulent variant 1716
8. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant: potential glioblastoma targeting
9. Selection in vitro replication of herpes simplex virus type 1 (HSV1), ICP34.5 null mutants in primary human CNS tumours - evaluation of a potentially effective clinical therapy
10. Therapeutic replication competent herpes virus
11. Toxicity evaluation of replication competent herpes simplex virus (ICP34.5 null mutant 1716) in patients with recurrent malignant glioma
12. Attempted modulation of herpes simplex virus (HSV) infection of neurons in culture by fibroblast growth factor
13. Establishment of pure neuronal cultures from fetal rat spinal cord and proliferation of the neuronal precursor cells in the presence of fibroblast growth factor
14. Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus
15. Identification of an adult-specific glial cell progenitor cell
16. Genetic studies with herpes simplex virus type 1. The isolation of temperature sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map
17. Modulation of Herpes Simplex Virus (HSV) infection of cultured neuronal cells by nerve growth factor and antibody to HSV
18. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders